[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 231
Citations 0
Comment & Response
November 2015

Glaucoma Surgery and Anticoagulant Therapy

Author Affiliations
  • 1Department of Ophthalmology, Jozef Strus Poznań City Hospital, Poznań, Poland
  • 2Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland
JAMA Ophthalmol. 2015;133(11):1364-1365. doi:10.1001/jamaophthalmol.2015.3071

To the Editor I read the article by Caldeira et al1 with great interest. However, some information given by the authors needs some critical discussion and verification.

The authors wrote, “Published consensus-based guidance specifically for the management of NOACs [novel oral anticoagulants] does not support the withdrawal of anticoagulation in patients undergoing cataract or glaucoma interventions,”1 and they cited the article titled “European Heart Rhythm Association Practical Guide on the Use of New Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation” by Heidbuchel et al.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×